Johnston, S., O’Shaughnessy, J., Martin, M., Huober, J., Toi, M., Sohn, J., . . . Goetz, M. P. (2021). Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups. Nature Portfolio.
Style de citation Chicago (17e éd.)Johnston, Stephen, et al. Abemaciclib as Initial Therapy for Advanced Breast Cancer: MONARCH 3 Updated Results in Prognostic Subgroups. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Johnston, Stephen, et al. Abemaciclib as Initial Therapy for Advanced Breast Cancer: MONARCH 3 Updated Results in Prognostic Subgroups. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.